Magazine Article | August 3, 2020

From Food To Pharma — Andrea Pfeifer's Trek To Cure Alzheimer's

Source: Life Science Leader

By Rob Wright, Chief Editor, Life Science Leader
Follow Me On Twitter @RfwrightLSL

“The first step was convincing my mother and husband that this was a good thing to do,” shares Andrea Pfeifer.

Apparently, the two thought she might be experiencing a midlife crisis. Why? Having completed a Ph.D. in toxicology and cancer research, followed by a post-doc in molecular carcinogenesis at the NIH in Bethesda, MD., Andrea Pfeifer had climbed the corporate ladder at Nestlé. In 2002 when she was having that conversation with her husband and mother, she was the head of Nestlé’s Global Research in Lausanne, Switzerland, with leadership responsibility for more than 600 people. Yet, despite her years of accomplishments at Nestlé, she was convinced it was time to leave the food industry behind and cofound AC Immune, a biopharma focused on one of the most difficult areas — Alzheimer’s disease (AD).

VIEW THE MAGAZINE ARTICLE!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Life Science Leader? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
I'm interested in newsletter subscriptions.
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: